Clinical Trial Update: The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating intrapolyp budesonide injections for managing chronic rhinosinusitis with nasal polyps has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Budesonide intrapolyp injection (budesonide)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 2, Phase 3 | Status: COMPLETED